The Lancet Neurology reports impact of daridorexant on both nighttime symptoms and daytime functioning in adults with insomnia
/PRNewswire/ -- As reported in the Lancet Neurology, daridorexant is the first insomnia medication to demonstrate an effect of a drug therapy to improve both...
United Kingdom United States France General Switzerland General Andrewc Weiss Ecole Normale Superieure Ulm
Source: prnewswire.com